Weili Sun

451 total citations
25 papers, 326 citations indexed

About

Weili Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weili Sun has authored 25 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Weili Sun's work include Immune Cell Function and Interaction (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Weili Sun is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Weili Sun collaborates with scholars based in China, Canada and United States. Weili Sun's co-authors include Xin Hu, Zhiao Chen, Yifei He, Xianghuo He, Hongquan Li, Weiguo Hu, Yizhe Liu, Qun‐Ying Lei, Zhen Liu and Xuhang Li and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Weili Sun

22 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weili Sun China 11 138 88 80 56 54 25 326
F. Merlin Italy 8 112 0.8× 167 1.9× 70 0.9× 72 1.3× 33 0.6× 18 504
Haifeng Lin China 8 98 0.7× 108 1.2× 70 0.9× 55 1.0× 52 1.0× 32 303
Zheyue Shu China 11 154 1.1× 58 0.7× 103 1.3× 40 0.7× 36 0.7× 23 337
Marion L. Hartley United States 10 100 0.7× 185 2.1× 59 0.7× 60 1.1× 48 0.9× 29 331
Nanya Wang China 13 150 1.1× 148 1.7× 71 0.9× 79 1.4× 120 2.2× 29 450
Laura Milesi Italy 9 132 1.0× 256 2.9× 89 1.1× 95 1.7× 22 0.4× 16 475
Wenfeng Liu China 10 111 0.8× 112 1.3× 50 0.6× 52 0.9× 45 0.8× 31 306
Alan I. Valderrama-Treviño Mexico 4 101 0.7× 161 1.8× 63 0.8× 87 1.6× 29 0.5× 28 387
Shaolin Ma China 11 199 1.4× 123 1.4× 75 0.9× 27 0.5× 42 0.8× 32 363
Kaibo Guo China 13 141 1.0× 175 2.0× 82 1.0× 121 2.2× 26 0.5× 44 431

Countries citing papers authored by Weili Sun

Since Specialization
Citations

This map shows the geographic impact of Weili Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Sun more than expected).

Fields of papers citing papers by Weili Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Sun. The network helps show where Weili Sun may publish in the future.

Co-authorship network of co-authors of Weili Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Sun. A scholar is included among the top collaborators of Weili Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Sun. Weili Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongquan, Yifei He, Zhen Liu, et al.. (2025). CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription. Nature Communications. 16(1). 7409–7409. 1 indexed citations
2.
Li, Xin, Weili Sun, Mengxing Huang, et al.. (2024). Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradation. Immunity. 57(7). 1603–1617.e7. 11 indexed citations
3.
4.
Ma, Peng & Weili Sun. (2023). Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer. Journal of Cancer Research and Clinical Oncology. 149(16). 14597–14617. 5 indexed citations
5.
Yuan, Yuan, et al.. (2023). [Screening and obataining of aptamers for the blood group antigen-binding adhesin (BabA) to block Helicobacter pylori (H.pylori) colonization in the stomach of mice].. PubMed. 39(9). 793–800. 1 indexed citations
6.
Li, Hongquan, Yifei He, Yizhe Liu, et al.. (2022). CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4‐Fatty Acid β‐Oxidation Pathway. Advanced Science. 9(21). e2105126–e2105126. 52 indexed citations
7.
Sun, Weili, et al.. (2021). The Value and Clinical Significance of Tumor Marker Detection in Cervical Cancer. Scientific Programming. 2021. 1–7. 7 indexed citations
8.
Tong, Haijun, Xin Li, Jinping Zhang, et al.. (2021). Ubiquitin Ligases CBL and CBL-B Maintain the Homeostasis and Immune Quiescence of Dendritic Cells. Frontiers in Immunology. 12. 757231–757231. 10 indexed citations
9.
Sun, Weili, et al.. (2021). Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice. International Immunopharmacology. 102. 108411–108411. 43 indexed citations
10.
Li, Xin, Liying Gong, Alexandre P. Meli, et al.. (2020). Cbl and Cbl-b control the germinal center reaction by facilitating naive B cell antigen processing. The Journal of Experimental Medicine. 217(9). 11 indexed citations
11.
Lian, Bi, Yu‐Chen Pei, Yi‐Zhou Jiang, et al.. (2020). Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer. Theranostics. 10(24). 11092–11109. 28 indexed citations
12.
Karras, Nicole, Bernard Tegtmeier, Weili Sun, et al.. (2020). Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience. Journal of Pediatric Hematology/Oncology. 42(4). 261–265. 9 indexed citations
13.
Pan, Yan, et al.. (2020). Research on the Application Value of Serum and Urine β2-Microglobulin in Immunoglobulin a Nephropathy. Clinical Laboratory. 66(07/2020). 1 indexed citations
14.
Wu, Yuan, Fei Yan, Weili Sun, et al.. (2019). <p>Retrospective study of the efficacy and toxicity of lobaplatin in combined chemotherapy for metastatic breast cancer</p>. OncoTargets and Therapy. Volume 12. 4849–4857. 9 indexed citations
15.
Sun, Weili, et al.. (2019). Unexpected mechanism of colitis amelioration by artesunate, a natural product from Artemisia annua L.. Inflammopharmacology. 28(4). 851–868. 24 indexed citations
16.
17.
Guo, Linwei, Linmiao Jiang, Yue Gong, et al.. (2018). Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer. Cancer Management and Research. Volume 10. 5881–5894. 16 indexed citations
18.
Yu, Gang, et al.. (2018). PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis.. PubMed. 10(6). 1793–1801. 17 indexed citations
19.
Wu, Yuan, Weili Sun, & Jifeng Feng. (2012). Antiangiogenic therapy in the management of breast cancer. Asia-Pacific Journal of Clinical Oncology. 9(2). 110–116. 5 indexed citations
20.
Sun, Weili, Guangyu Li, Hanlu Liu, et al.. (2012). Detection of Mink (Mustela vison) DNA in Meat Products using Polymerase Chain Reaction PCR Assay. Asian Journal of Animal and Veterinary Advances. 7(12). 1348–1355. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Merlin Breakdown of academic impact, for papers by Haifeng Lin Breakdown of academic impact, for papers by Zheyue Shu Breakdown of academic impact, for papers by Marion L. Hartley Breakdown of academic impact, for papers by Nanya Wang Breakdown of academic impact, for papers by Laura Milesi Breakdown of academic impact, for papers by Wenfeng Liu Breakdown of academic impact, for papers by Alan I. Valderrama-Treviño Breakdown of academic impact, for papers by Shaolin Ma Breakdown of academic impact, for papers by Kaibo Guo
Rankless by CCL
2026